Article

Revision and update on clinical practice guideline for liver cirrhosis.

Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
The Korean journal of hepatology 03/2012; 18(1):1-21. DOI: 10.3350/kjhep.2012.18.1.1
Source: PubMed
1 Bookmark
 · 
162 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Transferrin and alpha-1 antitrypsin are reportedly associated with liver fibrosis. We evaluated the usefulness of serum transferrin and alpha-1 antitrypsin as new liver fibrosis markers in patients with chronic hepatitis B. The study included 293 patients with chronic hepatitis B who underwent a liver biopsy between October 2005 and June 2009, and who had no history of hepatocellular carcinoma. Serum markers and liver fibrosis stages were compared. Univariate analysis revealed that age (P<0.001), serum platelet count (P<0.001), and serum alkaline phosphatase level (P=0.003) differed significantly between the patients with and without liver cirrhosis. Serum transferrin levels were significantly lower in advanced fibrosis than in mild fibrosis in both univariate analysis (P=0.002) and multivariate analysis (P=0.009). In addition, the serum transferrin level was significantly lower in cirrhotic patients than in noncirrhotic patients (P=0.020). However, the serum level of alpha-1 antitrypsin was not significantly associated with liver cirrhosis in patients with chronic hepatitis B. Serum transferrin could be promising serum marker for predicting advanced liver fibrosis in patients with chronic hepatitis B.
    Clinical and molecular hepatology. 12/2014; 20(4):347-54.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The excess consumption of alcohol is associated with alcoholic liver diseases (ALD). ALD is a major healthcare problem, personal and social burden, and significant reason for economic loss worldwide. The ALD spectrum includes alcoholic fatty liver, alcoholic hepatitis, cirrhosis, and the development of hepatocellular carcinoma. The diagnosis of ALD is based on a combination of clinical features, including a history of significant alcohol intake, evidence of liver disease, and laboratory findings. Abstinence is the most important treatment for ALD and the treatment plan varies according to the stage of the disease. Various treatments including abstinence, nutritional therapy, pharmacological therapy, psychotherapy, and surgery are currently available. For severe alcoholic hepatitis, corticosteroid or pentoxifylline are recommended based on the guidelines. In addition, new therapeutic targets are being under investigation.
    World journal of gastroenterology : WJG. 09/2014; 20(36):12934-12944.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nonalcoholic fatty liver disease (NAFLD) may be one of the important causes of cryptogenic hepatocellular carcinoma (HCC). The aim of this study was to evaluate whether patients with cryptogenic HCC share clinical features similar to that of NAFLD.
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 05/2014; 63(5):292-8.

Full-text (2 Sources)

Download
53 Downloads
Available from
May 20, 2014